Table 2.
Suboptimal bowel prep | |
Predictors | OR (95%CI)1 |
Age (yr) | |
50-59 | 1.0 |
60-69 | 1.1 (0.84-1.4) |
≥ 70 | 1.0 (0.67-1.6) |
Male gender | 0.99 (0.77-1.3) |
Race | |
White | 1.0 |
Black | 1.7 (1.2-2.4) |
Other | 1.2 (0.80-1.8) |
Body mass index (kg/m2) | |
< 30 | 1.0 |
≥ 30 | 1.3 (0.99-1.6) |
Clinical | |
Narcotics use | 1.8 (1.3-2.5) |
TCA use | 2.5 (1.4-4.6) |
Diagnosis of diabetes | 2.3 (1.7-3.1) |
GI fellow present | 1.1 (0.82-1.6) |
Polyps detected | 0.85 (0.68-1.1) |
Bowel prep type | |
4L PEG 3350 | 1.0 |
8L PEG 3350 | 0.52 (0.30-0.91) |
MiraLAX®/Gator ade® | 0.55 (0.39-0.76) |
Other | 0.76 (0.54-1.1) |
Endoscopy site | |
UMich Satellite Outpatient Units | 1.0 |
UMich in-Hospital Outpatient Unit | 1.3 (0.94-1.8) |
Veterans Affairs in-Hospital Unit | 1.6 (1.2-2.3) |
Effect adjusted for endoscopy site and GI fellow presence. TCA: Tricyclic antidepressants; GI: Gastroenterology; PEG: Polyethylene glycol; OR: Odds ratio.